Summary
BioSight, a privately-held pharmaceutical company developing innovative therapeutics for hematological malignancies and disorders.
Deals Overview
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
Senior Management
Ruth Ben Yakar
CEO
Roy Golan
CFO
Pini Orbach
Chairman